Autologous bone marrow cell transplantation in acute spinal cord injury - An Indian pilot study

Spinal Cord

Volumn 54, Issue 1, 2016, Pages 57-64

  Chhabra, H S ^a   Sarda, K ^a   Arora, Mohit ^a   Sharawat, R ^a   Singh, V ^a   Nanda, A ^a   Sangodimath, G M ^a   Tandon, V ^a  

^a INDIAN SPINAL INJURIES CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLADDER FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INDIAN; INTERNATIONAL SPINAL CORD INJURY SCALE; INTESTINE FUNCTION; LIVER ABSCESS; MALE; MOTOR DYSFUNCTION ASSESSMENT; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPASTICITY; SPINAL CORD INDEPENDENCE MEASURE; SPINAL CORD INJURY; ADOLESCENT; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; ELECTROPHYSIOLOGY; INDIA; NEUROLOGIC EXAMINATION; PROCEDURES; PSYCHOLOGIC TEST; RETROSPECTIVE STUDY; SPINAL CORD INJURIES; TREATMENT OUTCOME; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; ELECTROPHYSIOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; MALE; NEUROLOGIC EXAMINATION; PILOT PROJECTS; PSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SPINAL CORD INJURIES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84983200523     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2015.134     Document Type: Article

References (29)

1. Li J, Lepski G. Cell transplantation for spinal cord injury: a systematic review. Biomed Res Int 2013; 2013: 32.
2. Chhabra HS, Sarda K. Stem cell therapy in spinal trauma: does it have scientific validity?. Indian J Orthop 2015; 49: 56-71.
3. Chhabra HS, Lima C, Sachdeva S, Mittal A, Nigam V, Chaturvedi D et al. Autologous olfactory [corrected] mucosal transplant in chronic spinal cord injury: an Indian Pilot Study. Spinal Cord 2009; 47: 887-895.
4. Mackay-Sim A St, John JA. Olfactory ensheathing cells from the nose: clinical application in human spinal cord injuries. Exp Neurol 2011; 229: 174-180.
5. Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal CordMed 2006; 29: 191-203.
6. Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2001; 11: 3001-3005.
7. Sasaki M, Honmou O, Akiyama Y, Uede T, Hashi K, Kocsis JD. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia 2001; 35: 26-34.
8. Gu W, Zhang F, Xue Q, Ma Z, Lu P, Yu B. Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord. Neuropathology 2010; 30: 205-217.
9. Burns AS, Lee BS, Ditunno JF, Tessler A. Patient selection for clinical trials: the reliability of the early spinal cord injury examination. J Neurotrauma 2003; 20: 477-482.
10. Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, Auad AH et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 2008; 17: 1277-1293.
11. Sahni V, Kessler JA. Stem cell therapies for spinal cord injury. Nat Rev Neurol 2010; 6: 363-372.
12. Kishk NA, Gabr H, Hamdy S, Afifi L, Abokresha N, Mahmoud H et al. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair 2010; 24: 702-708.
13. Bhanot Y, Rao S, Ghosh D, Balaraju S, Radhika CR, Satish Kumar K V. Autologous mesenchymal stem cells in chronic spinal cord injury. Br J Neurosurg 2011; 25: 516-522.
14. Karamouzian S, Nematollahi-Mahani SN, Nakhaee N, Eskandary H. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. ClinNeurolNeurosurg 2012; 114: 935-939.
15. Jarocha D, Milczarek O, Kawecki Z, Wendrychowicz A, Kwiatkowski S, Majka M. Preliminary study of autologous bone marrow nucleated cells transplantation in children with spinal cord injury. Stem Cells Transl Med 2014; 3: 395-404.
16. Hewson SM, Fehlings LN, Messih M, Fehlings MG. The challenges of translating stem cells for spinal cord injury and related disorders: what are the barriers and opportunities?. Expert Rev Neurother 2013; 13: 143-150.
17. Liverman CT, Altevogt BM, Joy JE, Johnson RT. Spinal Cord Injury: Progress, Promise, and Priorities. National Academies Press, Washington D.C., USA: 2005.
18. Curt A, Van Hedel HJA, Klaus D, Dietz V. Recovery from a spinal cord injury: significance of compensation, neural plasticity, and repair. J Neurotrauma 2008; 25: 677-685.
19. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002; 99: 2199-2204.
20. Okano H, Ogawa Y, Nakamura M, Kaneko S, Iwanami A, Toyama Y. Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol 2003; 14: 191-198.
21. Yoon SH, Shim YS, Park YH, Chung JK, Nam JH, Kim MO et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 2007; 25: 2066-2073.
22. Tuszynski MH, Steeves JD, Fawcett JW, Lammertse D, Kalichman M, Rask C et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord 2007; 45: 222-231.
23. Wright KT, El Masri W, Osman A, Chowdhury J, Johnson WEB. Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells 2011; 29: 169-178.
24. Horner P, Gage F. Regenerating the damaged central nervous system. Nature 2000; 407: 963-970.
25. Ichim TE, Solano F, Lara F, Paris E, Ugalde F, Rodriguez JP et al. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med 2010; 3: 30.
26. Syková E, Homola A, Mazanec R, Lachmann H, Konrádová SL, Kobylka P et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006; 15: 675-687.
27. Dedeepiya VD, Rao YY, Jayakrishnan G a, JKBC Parthiban, Baskar S, Manjunath SR et al. Index of CD34+ cells and mononuclear cells in the bone marrow of spinal cord injury patients of different age groups: a comparative analysis. Bone Marrow Res 2012; 2012: 8.
28. Zariffa J, Kramer JLK, Fawcett JW, Lammertse DP, Blight AR, Guest J et al. Characterization of neurological recovery following traumatic sensorimotor complete thoracic spinal cord injury. Spinal Cord 2011; 49: 463-471.
29. Amr SM, Gouda A, Koptan WT, Galal AA, Abdel-Fattah DS, Rashed LA et al. Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-Transplantation with bone-marrow-Derived mesenchymal stem cells: case series of 14 patient. J Spinal Cord Med 2014; 37: 54-71.